US FDA Panel Sees Benefits To OTC Pathogen Tests, But Urges Caution
Executive Summary
An FDA panel concluded Aug. 16 that the benefits of over-the-counter tests for influenza, strep throat and certain sexually transmitted infections would likely outweigh the risks. But the group urged developers to take care in ensuring that the test results were easy for patients to interpret.